_compressed.jpg)
MVE/Brooks BioStore III Cryo LN2 Automated Storage System -190°C
MVE/Brooks
Details
-
CategoryCold Storage
-
Dimension68.0in x 62.0in x 76.0in
-
SerialCAB2121270043
-
Shipping TypeFreight
-
ManufacturingDoes Not Apply
-
Voltage / Hertz120V / 60Hz US
Description
The MVE/Brooks BioStore III Cryo LN2-Based Automated Storage System is a premier solution for laboratory cryogenic storage, designed for researchers and biobank managers. This high-efficiency system provides sample protection at temperatures as low as -190°C, ensuring the integrity of biosamples. The system offers comprehensive inventory management and control, with features including automated sample storage and retrieval, cold chain management, and multi-level security access. Its robust construction supports up to 252 cryoboxes, maintaining temperature stability for over 20 days even during power or LN2 loss. This system is sold in good condition; it powers on and performs basic tests with no known functionality issues, though a full test is unfeasible.
Technician comment
Featured image for display purposes only. Does not include pc or software. See photos for details.
Key Features
- LN2-based automated storage
- Operates at -190°C vapor phase
- Holds up to 252 cryoboxes
- Comprehensive inventory management
- 20+ days temperature stability during disruptions
- User access control and audit trail
Specifications
- Temperature range: -190°C vapor phase
- Storage capacity: up to 252 cryoboxes
- Power supply: 120V, 60Hz
- Weight: 1800 pounds
- Dimensions: 68.0 in (L) x 62.0 in (W) x 76.0 in (H)
- Sample integrity maintained below Tg
- Supports LIMS connectivity
Weight
Imperial: 2160.0 Pounds
Metric: 979.76 Kilograms
Shipping Dimensions
Imperial: 81.6 lb x 74.4 lb x 91.2 lb
Metric: 207.26 cm x 188.98 cm x 231.65 cm
Harmonized Code
8418302000
Harmonized Code Details
8418302000: Freezers of the chest type, not exceeding 900 L capacity. Chosen because this product is a specialized cryogenic freezer used for storage below -150°C.
Comments 0
There are currently no public comments.